vTv Therapeutics
Stock Forecast, Prediction & Price Target
vTv Therapeutics Financial Estimates
vTv Therapeutics Revenue Estimates
vTv Therapeutics EBITDA Estimates
vTv Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $4.00M N/A | $2.01M -49.61% | $0 -100% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-17.73M N/A | $-25.07M -41.40% | $-20.25M 19.23% | Avg: $-31.69M Low: $-31.69M High: $-31.69M avg. -56.50% | |||
EBITDA
% change YoY
| $-17.60M N/A | $-24.85M -41.20% | $-25.41M -2.22% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$11.32 N/A | -$13.06 -15.37% | -$9.71 25.65% | Avg: -$15.2 Low: -$15.2 High: -$15.2 avg. -56.53% | |||
Operating Expenses
% change YoY
| $25.66M N/A | $24.55M -4.32% | $11.90M -51.51% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is vTv Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -56.50% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -31.69M, average is -31.69M and high is -31.69M.
What is vTv Therapeutics stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is vTv Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -56.53% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$15.2, average is -$15.2 and high is $-15.2.
What is the best performing analyst?
In the last twelve months analysts have been covering vTv Therapeutics stock. The most successful analyst is Charles Duncan whose win rate is 100%. He has correctly predicted 1/1 price targets.